INCANTHERA ONCOLOGY LIMITED
76 KING STREET, MANCHESTER M2 4NH- Active
- Private Limited Company
- Company No. 07596505
- Last Updated: 01 Mar 2024
Company Profile
INCANTHERA ONCOLOGY LIMITED was incorporated on Thursday, April 7, 2011 as a Private Limited Company with registered address in MANCHESTER. INCANTHERA ONCOLOGY LIMITED has the status: Active and it's listed in the following category: Research and experimental development on biotechnology. This Private Limited Company has been operating for 13 years 5 months and 14 days.
| Name | INCANTHERA ONCOLOGY LIMITED |
|---|---|
| Company number | 07596505 |
| Company type | Private Limited Company |
| Incorporation date | 07 Apr 2011 |
| Status | Active |
| Industry (SIC 2007) |
Ownership Information
Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.
| Name | Nature of Control |
|---|---|
| Spark Northwest Gp Ltd Wood Street, L1 4DQ |
Dates: Tuesday, September 3, 2019 - Friday, February 28, 2020
voting rights 25 to 50 percent
|
| Dr Andrew Edward Round Nationality: British |
Dates: Wednesday, April 6, 2016 - Saturday, October 1, 2016
significant influence or control
|
| Nwf (Biomedical)Lp Mount Pleasant, L3 5TF |
Dates: Wednesday, April 6, 2016 - Tuesday, September 3, 2019
significant influence or control
|
| Incanthera Limited King Street, M2 4NH |
Dates: Wednesday, April 6, 2016 - present
ownership of shares 75 to 100 percent
|
Accounts and Confirmation
| Type of accounts | MICRO ENTITY |
|---|---|
| End of financial Year | 31 March |
| Next annual accounts due | 31 December 2024, (100 days left) |
| Latest accounts | 31 March 2023 |
| Next confirmation statement due | 28 August 2016 |
| Last confirmation statement dated | 31 July 2015 |
Mortgages
No mortgages have been registered against INCANTHERA ONCOLOGY LIMITED.
Previous Names
| Name | Change Date |
|---|---|
| INCANTHERA ONCOLOGY LIMITED | 07 Apr 2011 |
| FRIARS 656 LIMITED | 11 Apr 2011 |
| ONCO-NX LIMITED | 26 Feb 2020 |